Blinatumomab shows superior survival than conventional chemotherapy in paediatric patients with B-cell precursor acute ...
Company Announces Approximately $30 Million in Cash and Short-Term Investments Following Its October 27th Registered Direct Offering ...
Patients with chronic spontaneous urticaria who respond rapidly to omalizumab show longer treatment persistence and require ...
CULVER CITY, Calif.--(BUSINESS WIRE)--Immunotherapy innovator ImmunityBio, Inc. (NASDAQ: IBRX), today announced positive results from its QUILT 3.055 trial demonstrating long-term extended survival of ...
Dr. Charles M. Rudin highlighted new small cell lung cancer therapies, including T cell engagers, antibody-drug conjugates, ...
Planning a garden that can sustain you requires more than just picking your favorite vegetables. A survival garden is a ...
Radiation therapy treatment for breast cancer not only improves survival rates but also generates long-term financial ...
Elevated levels of five proteins in our blood can help predict risk of mortality, a new study from the University of Surrey ...
Genenta Science (Nasdaq: GNTA), a clinical-stage biotechnology company developing a cell-based platform for targeted delivery of therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback